Items where authors include "El Badri, S."
Up a levelArticle
El Badri, S., Tahir, B., Balachandran, K. et al. (18 more authors) (2021) Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer : a real-world multicentre UK study. The Breast, 60. pp. 199-205. ISSN 0960-9776
Brown, J.E. orcid.org/0000-0003-4960-3032, Wood, S.L., Confavreux, C. et al. (13 more authors) (2021) Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic : an international perspective and recommendations. Journal of Bone Oncology, 29. 100375. ISSN 2212-1374
Williams, S.T., El Badri, S. and Hussain, S.A. orcid.org/0000-0003-1552-511X (2021) Urological cancer patients receiving treatment during COVID-19 : a single-centre perspective. British Journal of Cancer, 124 (9). pp. 1513-1515. ISSN 0007-0920
Proceedings Paper
El Badri, S., Tahir, B. orcid.org/0000-0003-0531-3519, Balachandran, K. et al. (16 more authors) (2021) 245P Palbociclib combined with aromatase inhibitors (AIs) in women ≥75 years with oestrogen receptor positive (ER+ve), human epidermal growth factor receptor 2 negative (HER2-ve) advanced breast cancer: a real-world multicentre UK study. In: Annals of Oncology. ESMO Congress 2021, 16-21 Sep 2021, Virtual conference. Elsevier BV , S466-S466.